Livzon Group Fuzhou Fuxing Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is COLISTIMETHATE SODIUM, with a corresponding US DMF Number 28350.
Remarkably, this DMF maintains an Active status since its submission on May 30, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 12, 2019, and payment made on May 16, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II